本页面由Tiger Trade Technology Pte. Ltd.提供服务

Evelo Biosciences

0.0001
0.0000
成交量:70.00
成交额:0.00
市值:1,898.28
市盈率:0.00
高:0.0001
开:0.0001
低:0.0001
收:0.0001
52周最高:0.0025
52周最低:0.0000
股本:1,898.28万
流通股本:1,674.00万
量比:1.20
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-9.6476
每股收益(LYR):-26.2771
净资产收益率:-6232.76%
总资产收益率:-83.25%
市净率:-0.00
市盈率(LYR):0.00

数据加载中...

2024/01/27

重要事件披露

Form 8-K - Current report
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/12/27

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/12/04

重要事件披露

Form 8-K - Current report
2023/11/21

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/28

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/14

重要事件披露

Form 8-K - Current report
2023/07/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/12

重要事件披露

Form 8-K - Current report
2023/07/10

重要事件披露

Form 8-K - Current report
2023/07/08

重要事件披露

Form 8-K - Current report